Portal de Periódicos da CAPES

Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

2023; Massachusetts Medical Society; Volume: 388; Issue: 3 Linguagem: Inglês

10.1056/nejmoa2213082

1533-4406

Patricia L. Winokur, Juleen Gayed, David Fitz-Patrick, Stephen J. Thomas, Oyeniyi Diya, Stephen Lockhart, Xia Xu, Ying Zhang, Vishva Bangad, Howard I. Schwartz, Douglas Denham, Jose Cardona, Lisa Usdan, John Ginis, Federico Mensa, Jing Zou, Xuping Xie, Pei‐Yong Shi, Claire Lu, Sandra Buitrago, Ingrid L. Scully, David Cooper, Kenneth Koury, Kathrin U. Jansen, Özlem Türeci, Uğur Şahin, Kena A. Swanson, William C. Gruber, Nicholas Kitchin,

SARS-CoV-2 detection and testing

The emergence of immune-escape variants of severe acute respiratory syndrome coronavirus 2 warrants the use of sequence-adapted vaccines to provide protection against coronavirus disease 2019.